Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,308.00
0.00 (0.00%)
At close: Aug 14, 2026

Yungjin Pharm. Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2012FY 2011FY 2010FY 2009FY 2008
Period EndingSep '13 Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Revenue
158,787137,688112,105116,317103,376110,911
Revenue Growth
23.36%22.82%-3.62%12.52%-6.79%1.14%
Gross Profit
59,28448,38944,724116,31742,60148,422
Operating Income
9,8433,2684,086404.44-647.14408.44
Net Income
8,5281,7942,581-2,309-4,348-5,846
Earnings Per Share
53.4910.0015.00--36.76-49.42
EPS Growth
1199.63%-33.33%----

Cash & Debt

Fiscal YearCurrentFY 2012FY 2011FY 2010FY 2009FY 2008
Period EndingSep '13 Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Cash & Investments
4,6102,6706,62819,593817.851,110
Total Debt
28,05924,91727,84032,09047,07740,298
Net Cash (Debt)
-23,450-22,247-21,212-12,496-46,259-39,188
Net Cash Growth
------
Net Cash Per Share
-147.08-123.99-123.28--391.06-331.28

Cash Flow & CapEx

Fiscal YearTTMFY 2012FY 2011FY 2010FY 2009FY 2008
Period EndingSep '13 Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Operating Cash Flow
6,2862,3798,497--20.1510,305
Capital Expenditures
-5,092-3,146-13,824--3,621-5,448
Free Cash Flow
1,194-766.95-5,327--3,6414,857
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2012FY 2011FY 2010FY 2009FY 2008
Period EndingSep '13 Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Gross Margin
37.34%35.14%39.90%100.00%41.21%43.66%
Operating Margin
6.20%2.37%3.65%0.35%-0.63%0.37%
Pretax Margin
5.79%1.89%2.85%-1.56%-4.21%-0.71%
Profit Margin
5.37%1.30%2.30%-1.98%-4.21%-5.27%
FCF Margin
0.75%-0.56%-4.75%--3.52%4.38%

Valuation

Fiscal YearCurrentFY 2012FY 2011FY 2010FY 2009FY 2008
Period EndingAug '26 Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
PE Ratio
24.45160.37134.89---
P/FCF Ratio
200.39----19.00
PS Ratio
1.512.093.111.301.410.83